Taking it to the streets. Stockhouse.com: Taking it to the street
Cardium Therapeutics Inc  CXM go to snapshot add to favorites
reply post non-threaded view
print report abuse
Cardium Therapeutics, Inc. (CXM) Scheduled to Make
MissionIR2
8/30/2012 9:48:49 AM | No Recommendation | 78 reads  | Post #31444847
 

Cardium Therapeutics, Inc. (CXM) Scheduled to Make Presentation at the Rodman & Renshaw Annual 2012 Healthcare Investment Conference

Cardium Therapeutics today announced that Chairman & CEO Christopher J. Reinhard will be giving a presentation at the Rodman & Renshaw Annual Healthcare Investment Conference on Monday, September 10, 2012, at 3:15 p.m. Eastern Time. The conference is being held September 9-11, 2012, at the Waldorf-Astoria Hotel in New York City.

An audio webcast of the company’s presentation will be available both live and by replay at http://www.wsw.com/webcast/rrshq22/cxm as well as the Investors section of Cardium’s website at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-calendar. An updated investor presentation is now available on Cardium’s website at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.
 
Cardium Therapeutics is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium’s current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company’s in-house MedPodium Health Sciences healthy lifestyle product platform.
 
To learn more about the company, visit www.CardiumCXM.com

Please see disclaimer on the MissionIR website: http://www.missionir.com/disclaimer

 
 
reply post non-threaded view
add to favorites
 
Company Showcase
 
View Sectors
 
 
 
Today's Feature  
View Now
 
Pacific North West Capital Corp.
Pacific North West Capital Corp. (TSX: PFN; OTCQX: PAWEF; Frankfurt: P7J) is a mineral exploration company focused on the discovery, exploration and development of PGM and nickel-copper sulphide deposits in geologically prospective regions in North America, particularly Canada. The Company's key asset is its 100% owned River Valley PGM Project in the Sudbury region of northern Ontario. The River Valley Project is one of North America's most advanced primary PGM deposits...